MedTrace Logo

Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study

NCT05494710 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-08-10

No results posted yet for this study

Summary

The aim of the BEST study is to examine the feasibility of assessing patient and clinician reported outcome of a single electrosclerotherapy treatment of vascular malformations.

* Sclerotherapy = injection of Bleomycin into vascular birthmarks to seal off abnormal vascular channels
* Electroporation = application of an electric field to vessels treated with a handheld needle electrode
* Electrosclerotherapy = a combination of Bleomycin sclerotherapy and electroporation

Conditions

  • Vascular Malformations

Interventions

OTHER

Bleomycin electrosclerotherapy treatment

The combination of Bleomycin and electroporation of the treated area which is called electrochemotherapy (ECT).

Sponsors & Collaborators

  • Teesside University

    collaborator OTHER

  • South Tees Hospitals NHS Foundation Trust

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05494710 on ClinicalTrials.gov